Response to treatment of hepatitis C in HCV/HIV co-infected patients is not influenced by either abacavir or tenofovir with weight-based ribavirin

Detalles Bibliográficos
Autores principales: Bhatti, L, Shah, S, Khanlou, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112996/
http://dx.doi.org/10.1186/1758-2652-13-S4-P211
_version_ 1782205864543780864
author Bhatti, L
Shah, S
Khanlou, H
author_facet Bhatti, L
Shah, S
Khanlou, H
author_sort Bhatti, L
collection PubMed
description
format Online
Article
Text
id pubmed-3112996
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31129962011-06-13 Response to treatment of hepatitis C in HCV/HIV co-infected patients is not influenced by either abacavir or tenofovir with weight-based ribavirin Bhatti, L Shah, S Khanlou, H J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3112996/ http://dx.doi.org/10.1186/1758-2652-13-S4-P211 Text en Copyright ©2010 Bhatti et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Bhatti, L
Shah, S
Khanlou, H
Response to treatment of hepatitis C in HCV/HIV co-infected patients is not influenced by either abacavir or tenofovir with weight-based ribavirin
title Response to treatment of hepatitis C in HCV/HIV co-infected patients is not influenced by either abacavir or tenofovir with weight-based ribavirin
title_full Response to treatment of hepatitis C in HCV/HIV co-infected patients is not influenced by either abacavir or tenofovir with weight-based ribavirin
title_fullStr Response to treatment of hepatitis C in HCV/HIV co-infected patients is not influenced by either abacavir or tenofovir with weight-based ribavirin
title_full_unstemmed Response to treatment of hepatitis C in HCV/HIV co-infected patients is not influenced by either abacavir or tenofovir with weight-based ribavirin
title_short Response to treatment of hepatitis C in HCV/HIV co-infected patients is not influenced by either abacavir or tenofovir with weight-based ribavirin
title_sort response to treatment of hepatitis c in hcv/hiv co-infected patients is not influenced by either abacavir or tenofovir with weight-based ribavirin
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112996/
http://dx.doi.org/10.1186/1758-2652-13-S4-P211
work_keys_str_mv AT bhattil responsetotreatmentofhepatitiscinhcvhivcoinfectedpatientsisnotinfluencedbyeitherabacavirortenofovirwithweightbasedribavirin
AT shahs responsetotreatmentofhepatitiscinhcvhivcoinfectedpatientsisnotinfluencedbyeitherabacavirortenofovirwithweightbasedribavirin
AT khanlouh responsetotreatmentofhepatitiscinhcvhivcoinfectedpatientsisnotinfluencedbyeitherabacavirortenofovirwithweightbasedribavirin

Ejemplares similares